1）日本産科婦人科学会、日本病理学会編：絨毛性疾患取扱い規約第 3 版. 金原出 版：10‐32, 2011
2）大場 隆、三好潤也、片渕秀隆：絨毛性疾患の病態・病因論：胞状奇胎・侵入奇胎.
臨床婦人科産科 65：207-213, 2011
3 ） Soto-Wright V, Bernstein M, Goldstein DP, et al ： The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 86：775-779, 1995 4 ） Mazur MT, Kurman RJ ： Gestational trophoblastic disease. In diagnosis of endometrial biopsies and curettings, Mazur MT and Kurman RJ (eds), p.63-83, Springer-Verlag, New York, 1995
5）日本産科婦人科学会、日本病理学会編：絨毛性疾患取扱い規約第 2 版. 金原出 版：7-51, 1995
6）山辺 徹：婦人科腫瘍委員会報告（部分胞状奇胎の取り扱いに関する小委員会）.
日産婦誌 46：285-288, 1994
7）友田 豊、後藤節子：胞状奇胎娩出後の登録管理. 絨毛性疾患の診断と治療. 永 井書店：19-35, 1996
8）友田 豊：絨毛性疾患の臨床から学ぶ. 日産婦誌 47：701-709, 1995
9）Seckl MJ, Fisher RA, Salerno G, et al：Choriocarcinoma and partial hydatidiform moles. Lancet：356-359, 2000
10）Lazarus E, Hulka CA, Siewert B, et al：Sonographic appearance of early complete molar pregnancies. J Ultrasound Med 18：589-593, 1999
11）植木 實、工藤隆一、薬師寺道明：婦人科腫瘍委員会報告（絨毛性疾患地域登 録成績）.日産婦誌 52：988-999, 2000
47
12）Rua S, Fruttero A, Abrate M, et al：DNA flow cytometric analysis of abortion. A simple method for detection of triploidy and tetraploidy in the trophoblastic cells.
Pathologica 87：107-111, 1995
13）Berkowitz RS, Goldstein DP, Bernstein MR：Natural history of partial molar pregnancy. Obstet Gynecol 66：677-681, 1985
14）Fukunaga M：Early partial hydatidiform mole：prevalence, histopathology, DNA ploidy, and persistence rate. Virchows Arch 437：180-184, 2000
15）加藤秀則、和氣徳夫、ほか：胞状奇胎の遺伝子診断. 産婦の実際 55：607-612, 2006
16）Shih I-M, Mazur MT, Kurman RJ：2002 Gestational trophoblastic disease and related lesions. In：Kurman RJ, ed. Blaustein’s pathology of the female genital tract.
5th ed. New York：Springer-Verlag ; 1193-1247
17）大山和之、片渕秀隆、山本みのり、ほか：早期診断・管理を行った胞状奇胎の 2 例. 産婦治療 75：222-227, 1997
18）市原憲雄、大場 隆、片渕秀隆、ほか：嚢胞化絨毛が肉眼的に認められなかった 全胞状奇胎の 1 例. 日産婦熊本会誌 46：45-49, 2002
19）Tasci Y, Dibaz S, Secilmis O, et al：Routine histopathologic analysis of product of conception following first-trimester spontaneous miscarriages. J Obstet Gynaecol Res 31：579-82, 2005
20）Jeffers MD, O’Dwyer P, Curran B, Leader M, Gillan JE：Partial hydatidiform mole：
a common but underdiagnosed condition. Int J Gynecol Obstet 12：315-323, 1993 21）Berkowitz RS, Goldstein DP：The diagnosis of molar pregnancy by ultrasound：a continuing challenge. Ultrasound Obstet Gynecol 9：4-5, 1997
22 ） Tasci Y, Dibaz S, Secilmis O, Dilbaz B, Ozfuttu A, Haberal A ： Routine
48
histopathologic analysis of product of conception following first-trimester spontaneous miscarriges. J Obstet Gynecol Res 31：579-582, 2005
23）Lanzarus E, Hulka CA, Siewert B, Levine D：Sonographic appearance of early complete molar pregnancies. J Ultrasound Med 18：589-593, 1999
24 ） Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ: Histomorphometric features of hydatidiform moles in early pregnancy：relationship to detectability by ultrasound examination. Ultrasound Obstet Gynecol 29：76-80, 2007
25 ） Sebire NJ, Rees H, Paradinas F, Seckl MJ, Newlands E ： The diagnostic implications of routine ultrasound examination in histologically comfirmed early molar pregnancies. Ultrasound Obstet Gynecol 18：662-665, 2001
26）Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ：Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol 27：56-60, 2006
27）Johns J, Greenwold N, Buckley S, Jauniaux E：A prospective study of ultrasound screening for molar pregnancies in missed miscarriages. Ultrasound Obstet Gynecol 25：493-497, 2005
28）Sterier JA, Bergsjo P, Myking OL, et al：Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abortion, and removed ectopic pregnancy.
Obstet Gynecol 64：391-394, 1984
29）Marrs RP, Kletzky OA, Howard WF, et al：Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol 135：731-736, 1979
30）Aral K, Gurkan Zorlu C, Gokmen O, et al：Plasma human chorionic gonadotropin levels after induced abortion. Adv Contracept 12：11-14, 1996
49
31）Lähteenmäki P：The disappearance of HCG and return of pituitary function after abortion. Clin Endocrinol 9：101-112, 1978
32）江口 修、松井英雄、稲葉憲之、ほか：胞状奇胎後管理基準の設定に関する研究.
千葉医学雑誌 69：97-102, 1993
33）Wolfberg AJ, Berkowitz RS, Goldstein DP, et al：Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
Obstet Gynecol 106：548–552, 2005
34）van Trommel NE, Nqo Duo H, Massuqer LF, et al：Early identification of persistent trophoblastic disease with serum hCG concentration ratios. Int J Gynecol Cancer 18：318-323, 2008
35）Kerkmeijer L, Wielsma S, Massuger LF, et al：Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in the Netherlands.
Gynecol Oncol 106：142–146, 2007
36）Wolfberg AJ, Feltmate C, MD, Goldstein DP, et al：Low risk of relapse after achieving undetectable hCG levels in women with complete molar pregnancy. Obstet Gynecol 104：551-554, 2004
37）Batorfi J, Vegh G, Szepesi J, Szigetvari I, Doszpod J, Fulop V：How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data.
Eur J Obstet Gynecol Reprod Biol 112：95-97, 2004
38）Wolfberg AJ, Growdon WB, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES：Low risk of relapse after achieving undetectable hCG levels in women with partial molar pregnancy. Obstet Gynecol 108：393-396, 2006 39）Wielsma S, Kerkmeijer L, Bekkers R, et al：Persistent trophoblast disease following